The department shall:
(1) provide draft rules made under this chapter to the advisory board for the advisory board's review;
(2) consult with the advisory board regarding:
(a) patient education; and
(b) fees set by the department that pertain to the medical cannabis program; and
(3) when appropriate, consult with the advisory board regarding issues that arise in the medical cannabis program.